Catalent Receives "Preferred Partner Award in Technology" from Wyeth
Somerset, NJ, August 13, 2009 — Catalent Pharma Solutions’ softgel manufacturing site in St. Petersburg, Florida recently received a “Preferred Partner Award in Technology” from Wyeth Consumer Healthcare. The award, which recognizes Catalent’s support in 2008 for technical projects and documents, was presented to Janice Bachesais, Senior Client Services Specialist, and Dina Kostakis, General Manager for the site, which is included in Catalent’s Oral Technologies segment.
“We value our long-term partnership with Catalent, and appreciate the consistently high level of performance that this award recognizes,” said Jim Peck, Pharm.D., Technology Scientist IV, Wyeth Consumer Healthcare.
Wyeth Consumer Healthcare’s criteria for its “Preferred Partner Award in Technology” include measures regarding effective project support, consistent follow-through, “right first time” accuracy, and identification of process improvement opportunities. This is the third consecutive year that the St. Petersburg site received this award from Wyeth.
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at more than 30 facilities worldwide and in fiscal 2008 generated more than $1.8 billion in annual revenue. For more information, visit www.catalent.com .